Terug
Dagbereik
€ 8,18
€ 8,44
52-Weeksbereik
€ 5,80
€ 16,44
Volume
3.471.749
50D / 200D Gem.
€ 9,58
/
€ 11,13
Vorige Slotkoers
€ 8,10
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,8 | 0,2 |
| P/B | 2,8 | 3,0 |
| ROE % | -54,9 | 3,6 |
| Net Margin % | -513,2 | 3,8 |
| Rev Growth 5Y % | 4,5 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 27,00
+224.1%
Low: € 21,00
High: € 31,00
Forward WPA
-€ 1,35
Omzet Sch.
56,74M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,38
€ 0,72 – € 3,08
|
959,66M | 5 |
| FY2029 |
€ 0,03
€ 0,02 – € 0,06
|
579,19M | 2 |
| FY2028 |
-€ 0,97
-€ 2,00 – € 0,17
|
264,18M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-05 | -€ 0,32 | -€ 0,29 | +9,6% |
| 2025-11-04 | -€ 0,39 | -€ 0,37 | +5,1% |
| 2025-08-05 | -€ 0,35 | -€ 0,39 | -11,4% |
| 2025-05-05 | -€ 0,29 | -€ 0,37 | -27,6% |
| 2025-03-03 | -€ 0,24 | -€ 0,29 | -20,8% |
| 2024-11-14 | -€ 0,23 | -€ 0,26 | -13,0% |
| 2024-08-07 | -€ 0,22 | -€ 0,24 | -9,1% |
| 2024-05-07 | -€ 0,18 | -€ 0,24 | -33,3% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 4,46% annually over 5 years — modest growth
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -216,89M
Revenue growth is decelerating — 1Y growth trails 5Y average by 23,13%
Groei
Revenue Growth (5Y)
4,46%
Revenue (1Y)-18,67%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-54,85%
ROIC-27,59%
Net Margin-513,17%
Op. Margin-521,04%
Veiligheid
Debt / Equity
0,12
Current Ratio15,39
Interest Coverage-22,82
Waardering
P/E Ratio
-6,82
Forward P/EN/A
P/B Ratio2,77
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -18,67% | Revenue Growth (3Y) | -5,83% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 4,46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 51,82M | Net Income (TTM) | -265,94M |
| ROE | -54,85% | ROA | -32,91% |
| Gross Margin | 87,31% | Operating Margin | -521,04% |
| Net Margin | -513,17% | Free Cash Flow (TTM) | -216,89M |
| ROIC | -27,59% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 15,39 |
| Interest Coverage | -22,82 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6,82 | Forward P/E | N/A |
| P/B Ratio | 2,77 | P/S Ratio | 34,99 |
| PEG Ratio | -0,52 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 31,96 | Fwd Earnings Yield | N/A |
| FCF Yield | -11,96% | ||
| Market Cap | 1,81B | Enterprise Value | 1,16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 51,82M | 63,72M | 58,44M | 51,49M | 43,52M |
| Net Income | -265,94M | -193,51M | -80,74M | -71,04M | -6,55M |
| EPS (Diluted) | -1,42 | -1,22 | -1,02 | -0,97 | -0,98 |
| Gross Profit | 45,25M | 58,10M | 53,16M | 46,95M | 39,12M |
| Operating Income | -270,02M | -171,78M | -82,38M | -78,65M | -78,04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 808,06M | 457,94M | 252,06M | 149,29M | 204,89M |
| Total Liabilities | 153,75M | 142,59M | 160,93M | 113,91M | 116,89M |
| Shareholders' Equity | 654,31M | 315,34M | 91,13M | 35,38M | 88,00M |
| Total Debt | 79,78M | 75,78M | 83,39M | 64,28M | 58,98M |
| Cash & Equivalents | 737,06M | 392,10M | 195,81M | 102,30M | 164,16M |
| Current Assets | 782,13M | 440,99M | 232,24M | 129,63M | 191,30M |
| Current Liabilities | 50,81M | 41,35M | 34,90M | 31,40M | 26,34M |